tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AXSM Stock Latest News

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
Press ReleasesAxsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
4d ago
AXSM
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
PremiumPress Releases
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
9d ago
AXSM
Axsome Therapeutics initiates ENGAGE Phase 3 trial of solriamfetol
PremiumThe Fly
Axsome Therapeutics initiates ENGAGE Phase 3 trial of solriamfetol
18d ago
AXSM
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
PremiumPress Releases
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
18d ago
AXSM
Axsome Therapeutics price target raised to $109 from $108 at Mizuho
PremiumThe Fly
Axsome Therapeutics price target raised to $109 from $108 at Mizuho
22d ago
AXSM
3 Best Stocks to Buy Now, 3/27/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 3/27/2024, According to Top Analysts 
24d ago
AXSM
CRNX
Axsome Therapeutics price target raised to $128 from $123 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target raised to $128 from $123 at RBC Capital
24d ago
AXSM
Axsome Therapeutics price target raised to $190 from $180 at H.C. Wainwright
PremiumThe Fly
Axsome Therapeutics price target raised to $190 from $180 at H.C. Wainwright
25d ago
AXSM
Citi ups Axsome Therapeutics target, says selloff unwarranted
PremiumThe Fly
Citi ups Axsome Therapeutics target, says selloff unwarranted
25d ago
AXSM
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
PremiumPress Releases
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
25d ago
AXSM
Axsome Therapeutics announces results of CRESCENDO narcolepsy survy
PremiumThe Fly
Axsome Therapeutics announces results of CRESCENDO narcolepsy survy
25d ago
AXSM
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
PremiumPress Releases
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
25d ago
AXSM
Axsome Therapeutics says AXS-12 achieves primary endpoint in SYMPHONY trial
PremiumThe FlyAxsome Therapeutics says AXS-12 achieves primary endpoint in SYMPHONY trial
25d ago
AXSM
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
PremiumPress Releases
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
1M ago
AXSM
Axsome Therapeutics initiates PARADIGM Phase 3 trial of Solriamfetol
PremiumThe Fly
Axsome Therapeutics initiates PARADIGM Phase 3 trial of Solriamfetol
1M ago
AXSM
Axsome Therapeutics initiated with an Outperform at Baird
PremiumThe Fly
Axsome Therapeutics initiated with an Outperform at Baird
1M ago
AXSM
Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
PremiumPress Releases
Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
2M ago
AXSM
5 Best Biotech Stocks to Buy Now, According to Analysts – March 2024
PremiumMarket News
5 Best Biotech Stocks to Buy Now, According to Analysts – March 2024
2M ago
AMLX
AXSM
Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
PremiumPress Releases
Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
2M ago
AXSM
Axsome Therapeutics price target lowered to $108 from $112 at Mizuho
PremiumThe FlyAxsome Therapeutics price target lowered to $108 from $112 at Mizuho
2M ago
AXSM
Axsome Therapeutics price target lowered to $123 from $126 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target lowered to $123 from $126 at RBC Capital
2M ago
AXSM
Axsome Therapeutics price target lowered to $107 from $111 at UBS
PremiumThe Fly
Axsome Therapeutics price target lowered to $107 from $111 at UBS
2M ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >